23andMe just used your genetic data to create a drug for psoriasis

| | January 27, 2020
f aaabeaa b
Image: 23andMe
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Of the genetic testing company’s more than 10 million users, a vast majority have consented to have their DNA used in 23andMe’s research endeavors, which includes development of pharmaceuticals. If you’re one of these customers, you may not remember giving the company permission to conduct research with your saliva sample. Or maybe you didn’t read the fine print (23andMe has a separate consent process for research purposes).

If that’s you, turns out you’ve helped create a new drug meant to treat psoriasis, an autoimmune disease that causes red and scaly patches of skin. According to Bloomberg, 23andMe has sold the rights to that drug to the Spanish pharmaceutical company Almirall.

Related article:  'Why did I get cancer?' We can do more to alleviate 'angst, guilt' accompanying a diagnosis

Still, there’s a caveat even if you didn’t give the company your permission to use your DNA in aggregate: 23andMe says on its website that regardless of your consent status, the company may still include your data in any aggregate data that is disclosed to “third-party research partners” who will not publish that information publicly, such as in a scientific journal. In other words, researchers working with 23andMe can still see your data as part of an aggregate, anonymized dataset. That means it’s nearly impossible to tell exactly what all is being done with your genetic information.

Read the original post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
a a b b a f ac a

Video: Death by COVID: The projected grim toll in historical context

The latest statistics, as of July 10, show COVID-19-related deaths in U.S. are just under 1,000 per day nationally, which is ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
types of oak trees

Infographic: Power of evolution? How oak trees came to dominate North American forests

Over the course of some 56 million years, oaks, which all belong to the genus Quercus, evolved from a single undifferentiated ...
biotechnology worker x

Can GMOs rescue threatened plants and crops?

Some scientists and ecologists argue that humans are in the midst of an "extinction crisis" — the sixth wave of ...
food globe x

Are GMOs necessary to feed the world?

Experts estimate that agricultural production needs to roughly double in the coming decades. How can that be achieved? ...
eating gmo corn on the cob x

Are GMOs safe?

In 2015, 15 scientists and activists issued a statement, "No Scientific consensus on GMO safety," in the journal Environmental Sciences ...
Screen Shot at PM

Charles Benbrook: Agricultural economist and consultant for the organic industry and anti-biotechnology advocacy groups

Independent scientists rip Benbrook's co-authored commentary in New England Journal calling for reassessment of dangers of all GMO crops and herbicides ...
Screen Shot at PM

ETC Group: ‘Extreme’ biotechnology critic campaigns against synthetic biology and other forms of ‘extreme genetic engineering’

The ETC Group is an international environmental non-governmental organization (NGO) based in Canada whose stated purpose is to monitor "the impact of emerging technologies and ...
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend